跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,657 条关于
“Invasive Aspergillosis”
全部
9,657
临床试验
7,082
药物
17
机构
22
资讯
2,536
7个月前
Liposomal Amphotericin B Shows Comparable Efficacy to Triazoles in Invasive Aspergillosis Treatment
4个月前
F2G's Olorofim Shows Promise in High-Risk Hematology Patients with Invasive Aspergillosis
3年前
F2G's Olorofim Shows 44% Response Rate in Phase 2b Trial for Invasive Fungal Infections
2年前
F2G Secures $100 Million to Advance Antifungal Olorofim After FDA Rejection
8个月前
Pulmocide Terminates Phase 3 Trial of Inhaled Opelconazole After Interim Analysis Shows Higher Mortality
去年
Biosergen Completes Enrollment of First Cohort in BSG005 Proof-of-Concept Trial for Invasive Fungal Infections
去年
Basilea Secures $39 Million BARDA Funding to Advance Novel Antifungal Candidates Fosmanogepix and BAL2062
2个月前
Invasive Fungal Infections Market Poised for Robust Growth by 2036 as Novel Broad-Spectrum Antifungals Advance Through Pipeline
上个月
Basilea Secures $30 Million BARDA Tranche to Advance Fosmanogepix Phase III Program for Invasive Fungal Infections
去年
F2G's Novel Antifungal Olorofim Shows Promise Despite FDA Setback, Phase 2b Results Published in The Lancet
第 1 页,共 254 页
上一页
下一页